Long-term effect of a new oral prostacyclin analogue, beraprost sodium, in isolated peripheral pulmonary artery stenosis in the adult

Journal of Internal Medicine

Volumn 246, Issue 2, 1999, Pages 227-230

  Yoshitomi, Yuji ^a   Kojima, S ^a   Kuramochi, M ^a  

^a SHIZUOKA MEDICAL CENTER   (Japan)

Author keywords

Beraprost; Peripheral pulmonary artery stenosis; Prostacyclin; Pulmonary arterial pressure

Indexed keywords

BERAPROST; PROSTACYCLIN DERIVATIVE;

ADULT; ARTICLE; CASE REPORT; ECHOCARDIOGRAPHY; FEMALE; HEADACHE; HEART CATHETERIZATION; HEART RIGHT VENTRICLE PRESSURE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTENSION; LONG TERM EXPOSURE; LUNG ARTERY PRESSURE; LUNG PERFUSION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PULMONARY ARTERY STENOSIS;

EID: 0032813572     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.1999.00532.x     Document Type: Article

References (16)

1. McCue CM, Robertson LW, Lester RG, Mauck HP Jr. Pulmonary artery coarctations: a report of 20 cases with review of 319 cases from the literature. J Pediatr 1965; 67: 222-38.
2. Ichida F, Uese K, Tsubata S et al. Additive effect of beraprost on pulmonary vasodilation by inhaled nitric oxide in children with pulmonary hypertension. Am J Cardiol 1997; 80: 662-64.
3. Kreutzer J, Landzberg MJ. Preminger TJ et al. Isolated peripheral pulmonary artery stenoses in the adult. Circulation 1996; 93: 1417-23.
4. Baum D, Khoury GH, Ongley PA, Swan HJC Kincaid QW. Congenital stenosis of the pulmonary artery branches. Circulation 1964; 29: 680-87.
5. Edwards BS, Lucas RV, Lock JE, Edwards JE. Morphologic changes in the pulmonary arteries after percutaneous balloon angioplasty for pulmonary artery stenosis. Circulation 1985; 71: 195-201.
6. Rubin LJ, Mendoza J, Hood M et al. Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol): results of a randomized trial. Ann Intern Med 1990; 112: 485-91.
7. Data JL, Molony BA, Meinzinger MM, Gorman RR. Intravenous infusion of prostacyclin sodium in man: clinical effects and influence on platelet adenosine diphosphate sensitivity and adenosine 3′:5′-cyclic monophosphate levels. Circulation 1981; 64: 4-12.
8. Takeo S. Pharmacodynamics and clinical studies with beraprost sodium, a drug for peripheral vascular disease. Cardiovasc Drug Rev 1992; 10: 392-403.
9. Yuki H, Sato S, Arisaka Y, Kato S, Tomoike H. Orally administered beraprost sodium inhibits pulmonary hypertension induced by monocrotaline in rats. Tohoku J Exp Med 1994; 173: 371-75.
10. D'Alonzo GE, Barst RJ, Ayres SM et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med 1991; 115: 343-49.
11. Rothman A, Perry SB, Keane JF, Lock JE. Early results and follow-up of balloon angioplasty for branch pulmonary artery stenoses. J Am Coll Cardiol 1990; 15: 1109-17.
12. Gentles TL, Lock JE, Perry SB. High pressure balloon angioplasty for branch pulmonary artery stenosis: early experience. J Am Coll Cardiol 1993; 22: 867-72.
13. Benson LN, Hamilton F, Dasmahapatra H, Rabinowitch M, Coles JC, Preedom RM. Percutaneous implantation of a balloon-expandable endoprosthesis for pulmonary artery stenosis: an experimental study. J Am Coll Cardiol 1991; 18: 1303-308.
14. O'Laughlin MP, Slack MC, Grifka RG, Perry SB, Lock JE, Mullins CE. Implantation and intermediate-term follow-up of stents in congenital heart disease. Circulation 1993; 88: 605-14.
15. Franch RH, Gay RB Jr Congenital stenosis of the pulmonary artery brunches. Am J Med 1963; 35: 512-29.
16. Eldredge WJ, Tingelstad JB, Robertson LW, Mauck HP, McCue CM. Observations on the natural history of pulmonary artery coarctations. Circulation 1972; 45: 404-409.